Literature DB >> 2230276

Activity of the anthelmintic benzimidazoles against Giardia lamblia in vitro.

T D Edlind1, T L Hang, P R Chakraborty.   

Abstract

In vitro growth of the protozoan parasite Giardia lamblia was highly sensitive to certain anthelmintic benzimidazoles. Albendazole and mebendazole were 30- to 50-fold more active than metronidazole and 4- to 40-fold more active than quinacrine. Thiabendazole, a noncarbamate benzimidazole, was less active. Since lack of intestinal absorption makes mebendazole an attractive new antigiardial agent, its in vitro activity was further characterized. At low concentrations (0.05 micrograms/ml) mebendazole had a static effect on G. lamblia growth; however, lethal activity was observed at a concentration fivefold lower (0.3 micrograms/ml) than necessary for the cidal agent metronidazole. Two observations are consistent with a microtubule target for mebendazole. First, attachment of cells to the culture tube, mediated by the ventral disk and flagella, was rapidly disrupted by mebendazole treatment. Second, the characteristic cell structure was grossly distorted by treatment. No mebendazole-resistant G. lamblia were detected in a population of 10(8) cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2230276     DOI: 10.1093/infdis/162.6.1408

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  31 in total

1.  Drug susceptibility testing of anaerobic protozoa.

Authors:  J A Upcroft; P Upcroft
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 2.  Biology of Giardia lamblia.

Authors:  R D Adam
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

3.  In vitro effects of Crotalus durissus terrificus and Bothrops jararaca venoms on Giardia duodenalis trophozoites.

Authors:  Lina Shinohara; Stella Fellipe de Freitas; Reinaldo José da Silva; Semíramis Guimarães
Journal:  Parasitol Res       Date:  2005-12-24       Impact factor: 2.289

4.  The effects of saturated fatty acids on Giardia duodenalis trophozoites in vitro.

Authors:  Paran Rayan; Deborah Stenzel; Pauline Ann McDonnell
Journal:  Parasitol Res       Date:  2005-07-01       Impact factor: 2.289

5.  Discovery of a Stress-Activated Protein Kinase Inhibitor for Lymphatic Filariasis.

Authors:  Sreedhar R Tummalapalli; Rohit Bhat; Agnieszka Chojnowski; Monika Prorok; Tamara Kreiss; Ronald Goldberg; Stacie Canan; Natalie Hawryluk; Deborah Mortensen; Vikram Khetani; Jerome Zeldis; John J Siekierka; David P Rotella
Journal:  ACS Med Chem Lett       Date:  2018-02-09       Impact factor: 4.345

6.  Randomized clinical study of five days apostrophe therapy with mebendazole compared to quinacrine in the treatment of symptomatic giardiasis in children.

Authors:  Roberto Canete; Angel A Escobedo; Maria E Gonzalez; Pedro Almirall
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

7.  Structure-activity studies of dicationically substituted bis-benzimidazoles against Giardia lamblia: correlation of antigiardial activity with DNA binding affinity and giardial topoisomerase II inhibition.

Authors:  C A Bell; C C Dykstra; N A Naiman; M Cory; T A Fairley; R R Tidwell
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

8.  In vitro susceptibility of the opportunistic fungus Cryptococcus neoformans to anthelmintic benzimidazoles.

Authors:  M C Cruz; M S Bartlett; T D Edlind
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

Review 9.  Human antiprotozoal therapy: past, present, and future.

Authors:  M Khaw; C B Panosian
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

10.  Enhanced antiparasitic activity of lipophilic tetracyclines: role of uptake.

Authors:  S K Katiyar; T D Edlind
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.